Financhill
Back

Ligand Pharmaceuticals Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
59

LGND
Ligand Pharmaceuticals

Last Price:
110.05
Seasonality Move:
12.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Ligand Pharmaceuticals Price Quote

$110.05
-0.10 (0.01%)
(Updated: November 5, 2024 at 5:32 AM ET)

Ligand Pharmaceuticals Key Stats

Buy
59
Ligand Pharmaceuticals (LGND) is a Buy

Day range:
$108.11 - $110.63
52-week range:
$51.21 - $115.53
Dividend yield:
0%
P/E ratio:
37.47
P/S ratio:
14.69
P/B ratio:
2.6%

Volume:
84.8K
Avg. volume:
88.4K
1-year change:
104.02%
Market cap:
$2B
Revenue:
$131.3M
EPS:
$2.31

How Much Does Ligand Pharmaceuticals Make?

Is Ligand Pharmaceuticals Growing As A Company?

Ligand Pharmaceuticals Stock Price Performance

What Is Ligand Pharmaceuticals 52-Week High & Low?

Ligand Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ligand Pharmaceuticals?

Is Ligand Pharmaceuticals Cash Flow Positive?

  • What Is LGND Cash Flow From Operations?
    Cash flow from operations (TTM) is $47.8M
  • What Is Ligand Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $30.3M
  • What Is Ligand Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$88.3M

Ligand Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    LGND return on invested capital is 5.83%
  • What Is Ligand Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 5.15%
  • What Is LGND Return On Equity?
    ROE is a measure of profitability and is 5.83%

Ligand Pharmaceuticals Earnings Date & Stock Price

Ligand Pharmaceuticals Competitors

Ligand Pharmaceuticals Dividend Yield

Ligand Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 32.55%
Revenue: 57.52% 21.21%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 129.38
Upside from Last Price: 17.45%

Major Shareholders

  • How many LGND shares are owned by institutional investors?
    29.8M LGND shares are owned by institutional investors
  • How many LGND shares are owned by insiders?
    2M LGND shares are owned by insiders